ASM's stake in DNA is now worth less than $5 million, which is a whopping 0.5% of their billion dollar fund. Is 0.5% worth the time and effort of travelling to seedy Poipet, making 20 hour round trips to Sydney for shareholder meetings, negotiations with the Thai vendor, pleading with the CEO to stay on? Even if the price quadrupled, it wouldn't move the needle at all in their billion dollar fund.
If ASM cared so much for DNA, why didn't they participate in the capital raising? WHY? DNA is a waste of time for ASM and they have thrown in the towel.
But more importantly, why do you keep ramping up this stock?
ASM's stake in DNA is now worth less than $5 million, which is a...
-
- There are more pages in this discussion • 305 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
